June 1, 2023The Lancet202 citationsOpen Access

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Key points are not available for this paper at this time.

Valneva, Coalition for Epidemic Preparedness Innovation, and EU Horizon 2020.

AI से पूछें

Bookmark

View Full Paper

AI से पूछें

Bookmark

View Full Paper

Cite This Study